Literature DB >> 10078536

Cardiovascular data on sildenafil citrate: introduction.

R M Zusman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10078536     DOI： 10.1016/s0002-9149(99)00041-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Role of cGMP and cAMP in the hemodynamic response to intrathecal sildenafil administration.

Authors:  Gabriela Bombarda; João Paulo J Sabino; Carlos Alberto A da Silva; Rubens Fazan; Maria Cristina O Salgado; Helio C Salgado
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 2.  Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension.

Authors:  Steven G Chrysant
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial.

Authors:  Feiqiang Ren; Ziyang Ma; Yifeng Shen; Guangsen Li; Yaodong You; Xujun Yu; Zhengjie Li; Degui Chang; Peihai Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-07       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.